Game Changing Incentives in Drug Development

The 21st Century Cures Act is sweeping legislation approved and enacted in December of 2016. With increased funding for the NIH and FDA, more efficient use of those funds, efforts to expedite therapeutics for patients with rare diseases,and novel clinical trial designs, this legislation has broad relevance throughout the pharmaceutical industry.This webinar offers key insights for pharmaceutical executives, health care professionals,and health care analysts seeking insight into the future of FDA regulation and key trends in the industry.

Presenting this webinar are Denis Goldenberg, MBA, Vice President, Oncology Market Research & Commercial Analysis with Healthcare Research and Analytics (HRA), a leading market intelligence and healthcare analytics company. Denis brings more than 20 years of oncology-related experience, including more than 5 years of market research and analytics consulting experience.
Joining will be Michael R. Page, PharmD, RPh, Clinical Editor with Clinical Care Targeted Communications, a division of the American Journal of Managed Care. Michael is a registered pharmacist with more than 5 years of experience in healthcare communications and community pharmacy practice. 
Copyright HRA Data Driven Intelligence 1974-2019 HRA Data Driven Intelligence, LLC. All rights Reserved.
^